The business of veterinary care technology is both a lucrative and an impactful one—animal health company Zoetis brought in $7.8 billion in revenue in 2021 while developing vaccines and treatments for livestock and pets. Zoetis’s geographic footprint is as wide as its technological scope; the company oversees the production of veterinary biodevices and genetic tests from their design to manufacturing while providing services and products to over one hundred countries. In 2017, Zoetis launched its African Livestock Productivity and Health Advancement (ALPHA) Initiative with a grant from the Bill & Melinda Gates Foundation; ALPHA now provides veterinary technology and training resources to veterinarians and farmers in sub-Saharan Africa. The effort addresses food insecurity by giving small farmers the resources and training to sustainably keep livestock healthy. ALPHA currently operates 16 serology labs across Uganda, Nigeria, Tanzania, and Ethiopia. So far, 11 million chickens and over 45,000 cows have been tested for diseases through these labs. Even more important is the educational element of the initiative: In all, 26,000 farmers and veterinarians have been trained in livestock care and an estimated 1.3 million people have been reached through train-the-trainer programs. That education includes “an emphasis on training women,” senior director of sustainability and innovation communications Christina Lood told Fortune. The Zoetis Foundation has also recently focused on empowering America’s small-business dairy farmers to utilize sustainable technology.
Courtesy of Zoetis

Company Information

As of 10/10/2022
Parsippany, N.J.
Kristin Peck
Company Type
Revenues ($M)
Profits ($M)
Market Value ($M)
Market value as of Sept. 30, 2022.

Change the World

Impact Segment
Environmental Impact/Economic Opportunity
Health Care
Prior Year Rank
FortuneDataStore ad
Lists ranking Zoetis
Fortune 500 - 2022This year’s Fortune 500 marks the 68th running of ...READ MORE
Change the World - 2022...READ MORE